Tg(CMV-Plaur*)19Lbh
Transgene Detail
|
Symbol: |
Tg(CMV-Plaur*)19Lbh |
Name: |
transgene insertion 19, Lawrence B Holzman |
MGI ID: |
MGI:5613978 |
Synonyms: |
CMVflox-suPAR-FL |
Transgene: |
Tg(CMV-Plaur*)19Lbh Location: unknown
|
Alliance: |
Tg(CMV-Plaur*)19Lbh page
|
|
|
Transgene Type: |
|
Transgenic (Conditional ready, Inserted expressed sequence, No functional change) |
Mutation: |
|
Insertion
|
|
|
Tg(CMV-Plaur*)19Lbh expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Note |
mouse |
Plaur (MGI:97612) |
|
|
|
|
Mutation details: The construct is designed with the CMV-IE enhancer/chicken beta-actin hybrid promoter (CAG; from the pCAGGS vector), a loxP-flanked transcriptional STOP cassette (containing beta galactosidase and a polyadenylation signal), and the soluble form of the murine urokinase-type plasminogen activator receptor (Plaur) gene. The soluble form of Plaur (suPAR) encodes a 60 kDa truncated protein, lacking the glycophosphatidylinositol (GPI) anchored three domain (commonly referred to as D1, D2, D3) protein.
(J:217443)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:217443 Spinale JM, et al., A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int. 2015 Mar;87(3):564-74 |
All: |
1 reference(s) |
|